| 0.9727 -0 (-0.02%) | 09-04 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.18  |
1-year : | 1.26 |
| Resists | First : | 1.01 |
Second : | 1.08 |
| Pivot price | 1.01 |
|||
| Supports | First : | 0.91 |
Second : | 0.76 |
| MAs | MA(5) : | 0.97 |
MA(20) : | 1 |
| MA(100) : | 1.01 |
MA(250) : | 1.13 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 7.7 |
D(3) : | 9.3 |
| RSI | RSI(14): 45.4 |
|||
| 52-week | High : | 2.38 | Low : | 0.84 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CGC ] has closed above bottom band by 20.4%. Bollinger Bands are 21.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.98 - 0.99 | 0.99 - 0.99 |
| Low: | 0.94 - 0.95 | 0.95 - 0.96 |
| Close: | 0.96 - 0.97 | 0.97 - 0.98 |
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.
Sat, 05 Sep 2026
Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
Thu, 03 Sep 2026
Canopy Growth Company Profile & Introduction - Moomoo
Thu, 13 Aug 2026
Will Canopy Growth Get Acquired? - Yahoo Finance
Fri, 07 Aug 2026
Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Fri, 24 Jul 2026
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 423 (M) |
| Shares Float | 422 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 7.9 (%) |
| Shares Short | 24,900 (K) |
| Shares Short P.Month | 23,740 (K) |
| EPS | -0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.17 |
| Profit Margin | -79.3 % |
| Operating Margin | -21.7 % |
| Return on Assets (ttm) | -4 % |
| Return on Equity (ttm) | -39.6 % |
| Qtrly Rev. Growth | 12.5 % |
| Gross Profit (p.s.) | 0.19 |
| Sales Per Share | 0.69 |
| EBITDA (p.s.) | -0.07 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -78 (M) |
| Levered Free Cash Flow | 7 (M) |
| PE Ratio | -1.99 |
| PEG Ratio | 0 |
| Price to Book value | 0.82 |
| Price to Sales | 1.4 |
| Price to Cash Flow | -5.25 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|